Skip to main content
OpenTrials

Clinical trial condition

Skin Diseases, Eczematous

Explore clinical trials studying Skin Diseases, Eczematous. Study availability and eligibility vary by location and protocol.

1,455 public trials 170 recruiting studies
Refine in advanced search Browse all conditions

Skin Diseases, Eczematous trial results

Completed

Efficacy and Safety Study of CD2027 Ointment 3 Microgram Per Gram (mcg/g) Twice Daily Treatment for Adults With at Least Moderate Atopic Dermatitis

NCT00919763

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Burke Pharmaceutical Research Hot Springs, Arkansas, United States
  • Therapeutics Clinical Research, Inc. San Diego, California, United States
  • Colorado Medical Research Center, Inc. Denver, Colorado, United States
  • Longmont Medical Research Network Longmont, Colorado, United States
View all 14 locations
View Trial Details
Completed

Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy

NCT04345367

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Total Skin & Beauty Dermatology Center, PC Birmingham, Alabama, United States
  • Clinical Research Center Of Alabama Birmingham, Alabama, United States
  • Alliance Dermatology & MOHS Center, PC Phoenix, Arizona, United States
  • First OC Dermatology Fountain Valley, California, United States
View all 151 locations
View Trial Details
Completed

Crisaborole for Chinese and Japanese Subjects (≥2 Years of Age) With Mild to Moderate Atopic Dermatitis

NCT04360187

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Dermatology Hospital of Southern Medical University Guangzhou, Guangdong, China
  • Guangzhou First People's Hospital Guangzhou, Guangdong, China
  • The Second Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
View all 39 locations
View Trial Details
Completed

Study Of PF-06817024 In Healthy Subjects, In Patients With Chronic Rhinosinusitis With Nasal Polyps And in Patients With Atopic Dermatitis

NCT02743871

Conditions
Atopic Dermatitis, Chronic Rhinosinusitis With Nasal Polyps, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
Locations
  • UC Davis Dermatology Sacramento, California, United States
  • UC Davis CTSC Clinical Research Center Sacramento, California, United States
  • UC Davis Health Sacramento, California, United States
  • New Haven Clinical Research Unit New Haven, Connecticut, United States
View all 20 locations
View Trial Details
Completed

Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis.

NCT04250337

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Investigate MD Scottsdale, Arizona, United States
  • Orange County Research Institute Anaheim, California, United States
  • Bakersfield Dermatology and Skin Cancer Medical Group Bakersfield, California, United States
  • Wallace Medical Group, Inc. Beverly Hills, California, United States
View all 63 locations
View Trial Details
Completed

Subcutaneously CM310/Placebo in Patients With Moderate-to-Severe Atopic Dermatitis (AD)

NCT04805411

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations
  • Beijing Chao-Yang Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Beijing Friendship Hospital，Capital Medical University Beijing, Beijing Municipality, China
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
View all 25 locations
View Trial Details

Related conditions